• HPF (Hydroxyphenyl Fluorescein): Next-Gen hROS Detection in

  2026-05-26

  Explore the unique properties of HPF (hydroxyphenyl fluorescein) as a highly selective probe for detecting highly reactive oxygen species in complex cellular systems. This article delivers a deep analysis of HPF’s role in phototherapeutic research, practical assay design, and interprets recent breakthroughs for next-level intracellular oxidative stress visualization.

• Y-27632 dihydrochloride: ROCK Inhibitor for Advanced Cell Mo

  2026-05-25

  Y-27632 dihydrochloride is a benchmark ROCK inhibitor that enables reproducible cytoskeletal modulation, stem cell viability enhancement, and suppression of tumor invasion. This guide translates cutting-edge findings and real-world troubleshooting tips into actionable protocols, positioning APExBIO’s Y-27632 dihydrochloride as an essential reagent for high-impact biomedical research.

• LEE011 Succinate: Advanced CDK Inhibitor Workflows in Cancer

  2026-05-25

  Ribociclib succinate (LEE011 succinate) stands out as a CDK inhibitor with robust solubility and proven efficacy for HER2-positive breast cancer research. This guide delivers stepwise workflows, troubleshooting insights, and evidence-backed protocol optimizations that empower researchers to maximize reproducibility and precision in cell cycle studies.

• Lysis Buffer-Driven Mouse Genotyping: From DNA Extraction to

  2026-05-24

  Explore the pivotal role of lysis buffer, a rapid genotyping kit component, in extracting high-integrity genomic DNA from mouse tail samples. This article uniquely connects technical optimization with advances in cancer biomarker discovery, offering actionable insights for translational genetic research.

• Neurotensin (CAS 39379-15-2): Precision Tool for GPCR Traffi

  2026-05-23

  Neurotensin is a 13-amino acid neuropeptide and validated Neurotensin receptor 1 activator. It enables high-fidelity studies of GPCR trafficking mechanisms and miRNA regulation in gastrointestinal cells. The reagent’s purity and stability make it a trusted benchmark for mechanistic research.

• Deuterated CYP51 Inhibitors: Innovations Inspired by Oteseco

  2026-05-22

  This study introduces deuterated diphenyl azole alcohol CYP51 inhibitors, using Oteseconazole as a structural and pharmacological benchmark. The results reveal new compounds with potent antifungal activity and improved pharmacokinetics, offering promising leads for drug-resistant Candida infections.

• HyperPFU™ High-Fidelity DNA Polymerase: Technical PCR Guide

  2026-05-22

  HyperPFU™ high-fidelity DNA polymerase is designed for PCR amplification of long, GC-rich, or otherwise challenging DNA templates, where conventional Taq or lower-fidelity enzymes often fail due to errors or poor processivity. It should be used for workflows requiring blunt-ended, high-fidelity products, but is not suitable for protocols that rely on 3'-A overhangs or sticky ends.

• Optimizing Peptide Synthesis with HOBt (1-Hydroxybenzotriazo

  2026-05-21

  HOBt (1-Hydroxybenzotriazole) transforms amide bond formation by minimizing epimerization and boosting yields, even in demanding peptide and antibiotic derivative syntheses. Discover evidence-driven protocols, troubleshooting strategies, and the latest translational workflows that set APExBIO’s HOBt apart in advanced laboratory applications.

• Generation of Patient iPSC Lines for Mood Disorder Research

  2026-05-21

  This study reports the successful derivation and characterization of two induced pluripotent stem cell lines from a mother–child dyad affected by major depressive disorder and bipolar disorder. These genetically related iPSC lines provide a unique platform to investigate disease mechanisms and therapeutic strategies for mood disorders in a controlled genetic context.

• Prognostic Signature Integrates Autophagy and Metastasis in

  2026-05-20

  Bai et al. (2026) establish a rigorously validated prognostic risk signature for colorectal cancer (CRC) by integrating autophagy and liver metastasis gene expression using both bulk and single-cell transcriptomic data. This approach reveals how autophagy and metastasis collaboratively drive an immunosuppressive tumor microenvironment, impacting prognosis and therapeutic resistance.

• miR-196a Drives Esophageal Adenocarcinoma via MYC/TERT/NFκB

  2026-05-20

  A recent study reveals that overexpression of microRNA-196a promotes epithelial-to-mesenchymal transition (EMT) and aggressiveness in esophageal adenocarcinoma by activating the MYC/TERT/NFκB molecular axis. This mechanistic insight highlights c-Myc as a critical node in disease progression, offering new avenues for targeted intervention and translational cancer research.

• Early Pheromone Sensing Drives Neurodegeneration in C. elega

  2026-05-19

  Peng et al. (2023) demonstrate that early developmental perception of specific pheromones remodels neurodevelopment and accelerates neurodegeneration in adult C. elegans. This mechanistic insight reveals how environmental chemical signals can influence neuronal proteostasis and age-related neurodegenerative risk.

• GPER1 Activation Halts Prostate Cancer Progression in TRAMP

  2026-05-19

  This study demonstrates that activation of G-protein coupled estrogen receptor 1 (GPER1) can prevent the malignant progression of high-grade prostatic intraepithelial neoplasia (HGPIN) to prostate cancer in the TRAMP mouse model. The findings highlight GPER1 as a promising target for chemoprevention and provide mechanistic insight into its role in suppressing tumorigenic processes.

• Maternal Deltamethrin Exposure Impairs Offspring Memory via

  2026-05-18

  This study reveals that maternal exposure to the insecticide deltamethrin disrupts hippocampal function and impairs learning and memory in male offspring through a mechanism involving p53-mediated ferroptosis. The findings provide critical mechanistic insight into environmental neurotoxicity and highlight the utility of p53 pathway inhibitors in dissecting ferroptosis-dependent neurodevelopmental outcomes.

• Dissecting Drug Responses in Cancer: Insights from Advanced

  2026-05-18

  Schwartz’s dissertation pioneers a more nuanced framework for evaluating anti-cancer drug responses by distinguishing between proliferative arrest and cell death in vitro. The work’s methodical approach advances quantitative assessment in cancer drug research, guiding the interpretation and optimization of anti-proliferative agents.

555 records 17/37 page Previous Next First page 上5页 1617181920 下5页 Last page